NCT04623424 Intestinal Microbiota in Stem Cell Transplant Transplant Admission
| NCT ID | NCT04623424 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Henry Ford Health System |
| Condition | Stem Cell Transplant Complications |
| Study Type | OBSERVATIONAL |
| Enrollment | 255 participants |
| Start Date | 2020-11-03 |
| Primary Completion | 2028-11-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 255 participants in total. It began in 2020-11-03 with a primary completion date of 2028-11-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In this prospective study, the primary objective will be to investigate the association between the use of antibiotics administered during the admission period of Stem cell transplant (SCT) and the rate of overall change in microbiota composition across adjacent samples in time.
Eligibility Criteria
Inclusion Criteria: * Patients aged 18-80 years * patients undergoing allogenic or autologous SCT for malignant hematological conditions or bone marrow failure
Contact & Investigator
shatha farhan
PRINCIPAL INVESTIGATOR
Henry Ford
Frequently Asked Questions
Who can join the NCT04623424 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Stem Cell Transplant Complications. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04623424 currently recruiting?
Yes, NCT04623424 is actively recruiting participants. Contact the research team at SFARHAN1@HFHS.ORG for enrollment information.
Where is the NCT04623424 trial being conducted?
This trial is being conducted at Detroit, United States.
Who is sponsoring the NCT04623424 clinical trial?
NCT04623424 is sponsored by Henry Ford Health System. The principal investigator is shatha farhan at Henry Ford. The trial plans to enroll 255 participants.